159 related articles for article (PubMed ID: 26920997)
1. Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis.
Municio C; Soler Palacios B; Estrada-Capetillo L; Benguria A; Dopazo A; García-Lorenzo E; Fernández-Arroyo S; Joven J; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2016 Dec; 75(12):2157-2165. PubMed ID: 26920997
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate limits inflammation through an A20-dependent cross-tolerance mechanism.
Municio C; Dominguez-Soto Á; Fuentelsaz-Romero S; Lamana A; Montes N; Cuevas VD; Campos RG; Pablos JL; González-Álvaro I; Puig-Kröger A
Ann Rheum Dis; 2018 May; 77(5):752-759. PubMed ID: 29431121
[TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity.
Borman P; Taşbaş Ö; Karabulut H; Tukun A; Yorgancıoğlu R
Rev Bras Reumatol; 2015; 55(6):485-92. PubMed ID: 25687398
[TBL] [Abstract][Full Text] [Related]
4. Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.
Stamp LK; Hazlett J; Highton J; Hessian PA
J Rheumatol; 2013 Sep; 40(9):1519-22. PubMed ID: 23858048
[TBL] [Abstract][Full Text] [Related]
5. The effects of low-dose methotrexate on thymidylate synthetase activity in human peripheral blood mononuclear cells.
Hornung N; Stengaard-Pedersen K; Ehrnrooth E; Ellingsen T; Poulsen JH
Clin Exp Rheumatol; 2000; 18(6):691-8. PubMed ID: 11138330
[TBL] [Abstract][Full Text] [Related]
6. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism.
Ronda N; Greco D; Adorni MP; Zimetti F; Favari E; Hjeltnes G; Mikkelsen K; Borghi MO; Favalli EG; Gatti R; Hollan I; Meroni PL; Bernini F
Arthritis Rheumatol; 2015 May; 67(5):1155-64. PubMed ID: 25605003
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
Kumagai K; Hiyama K; Oyama T; Maeda H; Kohno N
Int J Mol Med; 2003 May; 11(5):593-600. PubMed ID: 12684695
[TBL] [Abstract][Full Text] [Related]
8. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.
van der Heijden JW; Oerlemans R; Tak PP; Assaraf YG; Kraan MC; Scheffer GL; van der Laken CJ; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
Arthritis Rheum; 2009 Mar; 60(3):669-77. PubMed ID: 19248091
[TBL] [Abstract][Full Text] [Related]
9. Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
Dervieux T; Furst D; Lein DO; Capps R; Smith K; Walsh M; Kremer J
Arthritis Rheum; 2004 Sep; 50(9):2766-74. PubMed ID: 15457444
[TBL] [Abstract][Full Text] [Related]
10. TYMS polymorphisms and responsiveness to or toxicity of methotrexate in rheumatoid arthritis.
Bae SC; Lee YH
Z Rheumatol; 2018 Nov; 77(9):824-832. PubMed ID: 29380036
[TBL] [Abstract][Full Text] [Related]
11. Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.
Blits M; Jansen G; Assaraf YG; van de Wiel MA; Lems WF; Nurmohamed MT; van Schaardenburg D; Voskuyl AE; Wolbink GJ; Vosslamber S; Verweij CL
Arthritis Rheum; 2013 Nov; 65(11):2791-802. PubMed ID: 23897011
[TBL] [Abstract][Full Text] [Related]
12. The Macrophage Reprogramming Ability of Antifolates Reveals Soluble CD14 as a Potential Biomarker for Methotrexate Response in Rheumatoid Arthritis.
Fuentelsaz-Romero S; Barrio-Alonso C; García Campos R; Torres Torresano M; Muller IB; Triguero-Martínez A; Nuño L; Villalba A; García-Vicuña R; Jansen G; Miranda-Carús ME; González-Álvaro I; Puig-Kröger A
Front Immunol; 2021; 12():776879. PubMed ID: 34804067
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate inhibits NF-κB activity via long intergenic (noncoding) RNA-p21 induction.
Spurlock CF; Tossberg JT; Matlock BK; Olsen NJ; Aune TM
Arthritis Rheumatol; 2014 Nov; 66(11):2947-57. PubMed ID: 25077978
[TBL] [Abstract][Full Text] [Related]
14. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
15. Effects of methotrexate on the expression of the translational isoforms of glucocorticoid receptors α and β: correlation with methotrexate efficacy in rheumatoid arthritis patients.
Gatica H; Aliste M; Guerrero J; Goecke IA
Rheumatology (Oxford); 2011 Sep; 50(9):1665-71. PubMed ID: 21642336
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate Provokes Disparate Folate Metabolism Gene Expression and Alternative Splicing in Ex Vivo Monocytes and GM-CSF- and M-CSF-Polarized Macrophages.
Muller IB; Lin M; de Jonge R; Will N; López-Navarro B; van der Laken C; Struys EA; Oudejans CBM; Assaraf YG; Cloos J; Puig-Kröger A; Jansen G
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298590
[TBL] [Abstract][Full Text] [Related]
17. Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A-dependent pro-inflammatory profile.
Soler Palacios B; Estrada-Capetillo L; Izquierdo E; Criado G; Nieto C; Municio C; González-Alvaro I; Sánchez-Mateos P; Pablos JL; Corbí AL; Puig-Kröger A
J Pathol; 2015 Feb; 235(3):515-26. PubMed ID: 25319955
[TBL] [Abstract][Full Text] [Related]
18. Differential influences of bucillamine and methotrexate on the generation of fibroblast-like cells from bone marrow CD34+ cells of rheumatoid arthritis patients.
Hirohata S; Yanagida T; Tomita T; Yoshikawa H
Int Immunopharmacol; 2009 Jan; 9(1):86-90. PubMed ID: 19000788
[TBL] [Abstract][Full Text] [Related]
19. Endogenous inspired biomineral-installed hyaluronan nanoparticles as pH-responsive carrier of methotrexate for rheumatoid arthritis.
Alam MM; Han HS; Sung S; Kang JH; Sa KH; Al Faruque H; Hong J; Nam EJ; Kim IS; Park JH; Kang YM
J Control Release; 2017 Apr; 252():62-72. PubMed ID: 28288894
[TBL] [Abstract][Full Text] [Related]
20. Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.
Ducreux J; Durez P; Galant C; Nzeusseu Toukap A; Van den Eynde B; Houssiau FA; Lauwerys BR
Arthritis Rheumatol; 2014 Jan; 66(1):15-23. PubMed ID: 24449571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
